INSTITUT CLAUDIUS REGAUD
🇫🇷France
CINSARC Genomic Signature as Predictor of Resectability of Ovarian Adenocarcinoma
Completed
- Conditions
- Ovarian Adenocarcinoma
- First Posted Date
- 2020-01-30
- Last Posted Date
- 2022-12-23
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 150
- Registration Number
- NCT04248231
- Locations
- 🇫🇷
Institut Claudius Regaud Institut Universitaire du cancer Toulouse Oncopole, Toulouse, France
E-monitoring of Patients Under Adjuvant Hormonotherapy for Breast Cancer.
Not Applicable
Completed
- Conditions
- Breast Cancer
- Interventions
- Other: Dedicated and coordinated monitoring
- First Posted Date
- 2020-01-14
- Last Posted Date
- 2021-07-27
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 45
- Registration Number
- NCT04228432
- Locations
- 🇫🇷
Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France
A Prospective Study to Collect Images in Patients Treated With Iodine-131 as Part of a European Research Project in Radiation Protection.
Completed
- Conditions
- Differentiated Thyroid Cancer
- First Posted Date
- 2019-06-14
- Last Posted Date
- 2021-05-27
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 29
- Registration Number
- NCT03986437
- Locations
- 🇫🇷
IUCT-O, Toulouse, France
Role of Surgery in Advanced Ovarian Cancer
Completed
- Conditions
- Ovarian Cancer
- First Posted Date
- 2019-06-10
- Last Posted Date
- 2019-06-10
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 550
- Registration Number
- NCT03980028
- Locations
- 🇫🇷
Institut Claudius Regaud - IUCT-Oncopole, Toulouse, Occitanie, France
Evaluation of the Adhesion to the GENEPY Network
- Conditions
- Hereditary Cancer SyndromeHereditary Breast and Ovarian CancerHereditary Colorectal Endometrial Cancer Syndrome
- First Posted Date
- 2019-06-07
- Last Posted Date
- 2019-06-07
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 450
- Registration Number
- NCT03979612
- Locations
- 🇫🇷
Institut Claudius Regaud - IUCT-Oncopole, Toulouse, Occitanie, France
Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma Group
Not Applicable
Recruiting
- Conditions
- Clear Cell SarcomaMalignant Solitary Fibrous TumorsEpithelioid HemangioendotheliomaSoft Tissue SarcomaPerivascular Epithelioid Cell NeoplasmsDesmoplastic Small Round Cell TumorAlveolar Soft Part SarcomaEpithelioid SarcomaLow Grade Fibromyxoid SarcomaSclerosing Epithelioid Fibrosarcoma
- Interventions
- Other: Patient with Soft Tissue Sarcoma
- First Posted Date
- 2019-05-30
- Last Posted Date
- 2024-08-02
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 400
- Registration Number
- NCT03967834
- Locations
- 🇫🇷
Chu Besancon - Site Jean Minjoz, Besancon, France
🇫🇷Institut Bergonié, Bordeaux, France
🇫🇷Centre Jean Perrin, Clermont-Ferrand, France
A Clinical Study Evaluating the Safety of Peptide Receptor Radionuclide Therapy (PRRT) With 177Lu-DOTA0-Tyr3-Octreotate in Children With Refractory or Recurrent Neuroblastoma Expressing Somatostatin Receptors.
- First Posted Date
- 2019-05-29
- Last Posted Date
- 2025-02-04
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 18
- Registration Number
- NCT03966651
- Locations
- 🇫🇷
CHU Besançon, Besançon, France
🇫🇷CHU Pellegrin, Bordeaux, France
🇫🇷CHU Dijon, Dijon, France
Deciphering Mechanisms Underlying Cancer Immunogenicity
Not Applicable
Recruiting
- Conditions
- Head and Neck CancerNon Small Cell Lung CancerCervical Intraepithelial Neoplasia 3Ovarian CancerGlioblastoma Multiforme of Brain StemAnal CancerCervical Cancer
- Interventions
- Other: Blood samples, tumor biopsy specimens and ascites samples will be collected.
- First Posted Date
- 2019-05-21
- Last Posted Date
- 2024-07-24
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 900
- Registration Number
- NCT03958240
- Locations
- 🇫🇷
Hopital Larrey, Toulouse, France
🇫🇷Hopital Rangueil, Toulouse, France
🇫🇷Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse, France
Evaluation of Low-Level Laser Therapy Efficacy in Pain Management of Grade 2 Oral Mucositis Induced by Radiotherapy or Chemoradiotherapy: a Study in Patients With Upper Aerodigestive Tract Cancer
Phase 2
Withdrawn
- Conditions
- Upper Aerodigestive Tract Neoplasms
- Interventions
- Other: Basic Oral CareDevice: Basic Oral Care + active LLLTOther: Basic oral Care + inactive LLLT
- First Posted Date
- 2019-05-20
- Last Posted Date
- 2021-04-08
- Lead Sponsor
- Institut Claudius Regaud
- Registration Number
- NCT03955224
- Locations
- 🇫🇷
Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France
Impact of a Sexological Follow-up on the Sexual Function in Patients With Cervix or Vaginal Cancer Treated by Radiotherapy and Brachytherapy
Not Applicable
Completed
- Conditions
- Cervix CancerVaginal Cancer
- Interventions
- Other: Patients with cervix or vaginal cancer treated by radiotherapy and brachytherapy
- First Posted Date
- 2019-05-20
- Last Posted Date
- 2022-03-24
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 60
- Registration Number
- NCT03956498
- Locations
- 🇫🇷
Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France
© Copyright 2025. All Rights Reserved by MedPath